OVERVIEW

Advanced eBytes: Osteoporosis: Approach to Selecting Pharmacologic Treatment is organized by American College of Rheumatology (ACR) and will be held from Dec 19, 2018 - Dec 19, 2021.

Target Audience
The target audience is physicians, fellows-in-training, nurse practitioners, physician assistants, nurses, practice managers, physical therapists, occupational therapists, pharmacists, and medical and health professional students involved in the care of patients with rheumatic disease.

Accreditation
Designation Statement
The ACR designates this online activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

Course Description :
Advanced Rheumatology eBytes were created to complement the Advanced Rheumatology Course by allowing you to get a “bite-size” of education while receiving CME credits at any time that is convenient for you. Free for ACR/ARP members!

One area this activity will cover is whether or not the risks of Osteonecrosis of the Jaw (ONJ) in patients taking bisphosphonates or denosumab are low enough to receive the dental care required (e.g. implants, extractions).
Includes the following:
• Audio presentation
• Post-assessment
• Activity evaluation

Course Objectives :
Upon completion of this activity, participants should be able to:
• Identify and discuss the initial and long-term approach to the selection of pharmacologic agents for osteoporosis based upon safety and efficacy

Additional details will be posted as soon as they are available.